MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 07-31-2025
OPKO Health Total Current Liabilities 2011-2026 | OPK
Annual Total Current Liabilities OPKO Health
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 193 M | 200 M | 213 M | 330 M | 375 M | 249 M | 288 M | 312 M | 263 M | 252 M | 83.1 M | 91.8 M | 52.4 M | 18.8 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 375 M | 18.8 M | 209 M |
Total Current Liabilities of other stocks in the Diagnostics research industry
| Issuer | Total Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Agilent Technologies
A
|
1.71 B | $ 118.25 | -1.27 % | $ 35.9 B |  USA |
 |
Burning Rock Biotech Limited
BNR
|
372 M | $ 22.5 | 9.44 % | $ 242 M |  China |
 |
Accelerate Diagnostics
AXDX
|
66.6 M | - | -61.36 % | $ 2.46 M | USA |
 |
Aspira Women's Health
AWH
|
3.46 M | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
5.51 M | - | -13.05 % | $ 7.29 M | USA |
 |
Check-Cap Ltd.
CHEK
|
1.81 M | - | - | $ 9.42 M |  Israel |
 |
Chembio Diagnostics
CEMI
|
39.3 M | - | 0.22 % | $ 16.8 M | USA |
 |
CareDx, Inc
CDNA
|
89.8 M | $ 22.42 | 27.6 % | $ 1.19 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
13.8 M | - | - | $ 562 M |  Britain |
 |
DermTech
DMTK
|
13.4 M | - | -11.32 % | $ 2.94 M | USA |
 |
Akumin
AKU
|
169 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Enzo Biochem
ENZ
|
24.8 M | - | -8.98 % | $ 14.8 K | USA |
 |
Co-Diagnostics
CODX
|
3.54 M | $ 1.46 | 2.82 % | $ 1.94 M | USA |
 |
Exact Sciences Corporation
EXAS
|
641 M | - | - | $ 19.8 B | USA |
 |
Castle Biosciences
CSTL
|
49.4 M | $ 24.56 | -0.24 % | $ 682 M | USA |
 |
Global Cord Blood Corporation
CO
|
647 M | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
54.2 M | - | 1.08 % | $ 308 M | USA |
 |
Charles River Laboratories International
CRL
|
1.12 B | $ 176.94 | -2.0 % | $ 8.77 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.27 B | - | - | $ 10.7 B | USA |
 |
Danaher Corporation
DHR
|
6.81 B | $ 193.78 | -2.18 % | $ 138 B | USA |
 |
Interpace Biosciences
IDXG
|
5.1 M | $ 2.2 | - | $ 9.73 M | USA |
 |
Heska Corporation
HSKA
|
39.6 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
8.27 M | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
1.55 B | $ 132.72 | 0.35 % | $ 21.1 B | USA |
 |
Fulgent Genetics
FLGT
|
72.9 M | $ 16.13 | -0.25 % | $ 488 M | USA |
 |
Medpace Holdings
MEDP
|
1.34 B | $ 515.65 | -0.56 % | $ 14.9 B | USA |
 |
Guardant Health
GH
|
303 M | $ 85.7 | 0.99 % | $ 10.7 B | USA |
 |
QIAGEN N.V.
QGEN
|
512 M | - | - | $ 10.6 B |  Niderland |
 |
Anixa Biosciences
ANIX
|
1.97 M | $ 2.83 | -3.41 % | $ 91.8 K | USA |
 |
Biomerica
BMRA
|
1.74 M | $ 2.2 | 4.27 % | $ 5.05 M | USA |
 |
Motus GI Holdings
MOTS
|
3.27 M | - | -34.28 % | $ 263 K | Israel |
 |
ICON Public Limited Company
ICLR
|
2.8 B | $ 115.58 | -0.79 % | $ 9.53 B |  Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
2.82 B | $ 266.36 | -0.14 % | $ 22.2 B | USA |
 |
Celcuity
CELC
|
44.2 M | $ 125.25 | 1.44 % | $ 5.86 B | USA |
 |
Lantheus Holdings
LNTH
|
333 M | $ 83.92 | -0.02 % | $ 5.66 B | USA |
 |
Myriad Genetics
MYGN
|
134 M | $ 5.0 | -3.66 % | $ 463 M | USA |
 |
NeoGenomics
NEO
|
88.3 M | $ 8.16 | -5.99 % | $ 1.05 B | USA |
 |
Neogen Corporation
NEOG
|
174 M | $ 9.24 | -1.91 % | $ 2 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
2.28 B | $ 191.46 | 0.02 % | $ 21.3 B | USA |
 |
ENDRA Life Sciences
NDRA
|
751 K | $ 5.17 | 0.58 % | $ 4.07 M | USA |
 |
National Research Corporation
NRC
|
36.6 M | $ 17.62 | -1.23 % | $ 394 M | USA |
 |
Invitae Corporation
NVTA
|
108 M | - | - | $ 21.2 M | USA |
 |
Natera
NTRA
|
310 M | $ 196.11 | -5.35 % | $ 19.3 B | USA |
 |
Organovo Holdings
ONVO
|
3.74 M | - | -2.3 % | $ 19.4 M | USA |
 |
OpGen
OPGN
|
634 K | - | -16.95 % | $ 1.54 M | USA |
 |
PerkinElmer
PKI
|
1.33 B | - | -0.91 % | $ 14.7 B | USA |